- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2364-3420
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting tumor cells with antibodies enhances anti-tumor immunity ; volume:4 ; number:5 ; day:29 ; month:10 ; year:2018 ; pages:243-253 ; date:10.2018
Biophysics reports ; 4, Heft 5 (29.10.2018), 243-253, 10.2018
- Creator
-
Sun, Zhichen
Fu, Yang-Xin
Peng, Hua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41048-018-0070-2
- URN
-
urn:nbn:de:101:1-2018123119174553142849
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sun, Zhichen
- Fu, Yang-Xin
- Peng, Hua
- SpringerLink (Online service)
Other Objects (12)
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
TH9 cells in anti-tumor immunity
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
TH9 cells in anti-tumor immunity
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity
Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
TH9 cells in anti-tumor immunity
Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
Necroptosis stimulates interferon-mediated protective anti-tumor immunity
Tumor immune microenvironment (TIME) to enhance antitumor immunity
Integrin CD11b activation drives anti-tumor innate immunity